The research has shown that these vesicles, dubbed BP-EVs, have a high potential to be used as nanovectors for drug delivery. "The finding, which was protected by a European patent last November, indi...
Read moreThe research group BioNanoTools of CiQUS of USC led by Beatriz Pelaz and Pablo del Pino, has just published a paper in the journal Nanoscale that advances in injectable drug delivery systems. The arti...
Read moreAmbos estudios han contado con el apoyo del Grupo Español de Tumores Neuroendocrinos y Endocrinos (GETNE) y son una muestra de como la investigación académica, al margen de la industria farmacéuti...
Read moreMinoryx Therapeutics announces that it has filed a Marketing Authorization Application (MAA) for its lead candidate leriglitazone to the European Medicines Agency (EMA) for the treatment of adult male...
Read moreSeagen to Develop and Commercialize LAVA-1223, a Bispecific T Cell Engager Designed to Target and Activate Vγ9Vδ2 (Gamma Delta) T Cells in the Presence of EGFR-Expressing Solid Tumors
Read moreMinoryx Therapeutics, a late-stage biotech company focused on the development of treatments for orphan central nervous system (CNS) disorders and the Neuraxpharm Group (“Neuraxpharm”), a leading E...
Read moreLa polipíldora merecedora del premio ABC Salud ha presentado resultados de un estudio que aporta evidencia de una reducción del 33 por ciento en mortalidad por causa cardiovascular.
Read moreLa investigación trata de desarrollar un nuevo fármaco dirigida a una proteína que se produce en el ambiente tumoral. El fármaco se basa en un anticuerpo frente a esa proteína, que se denomina FA...
Read moreVarmX, a biotech company focusing on the development of innovative approaches for the reversal of anticoagulation, today announces it has successfully raised an additional €30 million in a Series B2...
Read moreThis approach led Center for Research in Biological Chemistry and Molecular Materials (CiQUS) researchers to mimic the membrane composition of tumour cells and develop new lipid-based nanocarriers tha...
Read moreThe MAF-TEST® predicts the prognosis of breast cancer patients and helps oncologists to identify those patients who may be able to prevent recurrence and benefit from adjuvant treatment with bisphosp...
Read moreLa aprobación del fármaco Leqvio (inclisirán), que permite reducir los niveles de colesterol LDL con dos dosis al año, ha marcado un hito en las estrategias terapéuticas para abordar las enfermed...
Read more